|
EPRS expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.900100E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.456300E-02 |
| Normal-vs-Stage2 |
3.843800E-01 |
| Normal-vs-Stage3 |
2.778000E-03 |
| Normal-vs-Stage4 |
6.297600E-03 |
| Stage1-vs-Stage2 |
5.480600E-01 |
| Stage1-vs-Stage3 |
6.860300E-02 |
| Stage1-vs-Stage4 |
2.079000E-01 |
| Stage2-vs-Stage3 |
9.797800E-02 |
| Stage2-vs-Stage4 |
1.671600E-01 |
| Stage3-vs-Stage4 |
7.431000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.028100E-02 |
| Normal-vs-AfricanAmerican |
1.63453999999508E-05 |
| Normal-vs-Asian |
7.718000E-02 |
| Caucasian-vs-AfricanAmerican |
5.969600E-04 |
| Caucasian-vs-Asian |
3.979200E-01 |
| AfricanAmerican-vs-Asian |
7.522600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.163900E-02 |
| Normal-vs-Female |
5.735800E-03 |
| Male-vs-Female |
5.814800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.022300E-02 |
| Normal-vs-Age(41-60Yrs) |
5.323700E-03 |
| Normal-vs-Age(61-80Yrs) |
4.754400E-02 |
| Normal-vs-Age(81-100Yrs) |
8.304500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.491400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.702600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.939200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.920400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.486800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.105800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.973800E-01 |
| Normal-vs-Grade 2 |
5.267900E-02 |
| Normal-vs-Grade 3 |
6.404700E-03 |
| Normal-vs-Grade 4 |
4.138500E-03 |
| Grade 1-vs-Grade 2 |
5.669200E-01 |
| Grade 1-vs-Grade 3 |
3.247400E-01 |
| Grade 1-vs-Grade 4 |
2.088200E-01 |
| Grade 2-vs-Grade 3 |
1.993780E-01 |
| Grade 2-vs-Grade 4 |
9.284000E-02 |
| Grade 3-vs-Grade 4 |
4.762200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.692400E-01 |
| Normal-vs-ccB subtype |
2.037600E-03 |
| ccA subtype-vs-ccB subtype |
2.008900E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.180600E-03 |
| Normal-vs-N1 |
9.850600E-01 |
| N0-vs-N1 |
3.867600E-01 |
|
|
